RxDoctor Payments Data

Michael Thompson, MD

Hand Surgery · la Jolla, CANPI 1356313167

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (34.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Trimed, Inc. at 44.8% of the total. 2025 is the largest year on record at $3,311, 5.6 times the $594 reported in 2019.

$6,975in general payments, 2019–2025

Across 38 payments — averaging $183.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trimed, Inc.$3K
  • Impactortho, Inc.$2K
  • Biogen$364
  • Endo Pharmaceuticals Inc.$142
  • Endo USA, Inc.$128
  • Integra Lifesciences Corporation$111
  • plus $705 from 12 others
$8,766,351in research payments, 2019–2025

Across 2 payments — averaging $4,383,176 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$8.8M

What the payments were for

  • Speaking & faculty fees$1,50022%
  • Travel & lodging$1,52422%
  • Food & beverage$1,55122%
  • Education$2,40034%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,975 in reported general payments places this provider in the 70th percentile of 249 hand surgery providers in California.

See all hand surgery providers in California

Medicare billing

Part B allowed, 2024
$363,701
Medicare patients
551
Services billed
18,602

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib58$1,123
Gabapentin59$227
Doxycycline Hyclate16$154
Oxycodone Hcl12$43

Paid to pharmacies, not to this prescriber.

Other hand surgery in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →